LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.00043333
90.55 27.76 11354 6928 1.6387 1.1280
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
92.25 27.76 856 6873 0.1245 0.5391
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
92.25 27.76 13900 6873 2.0223 1.1852
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
92.25 27.76 9587 6873 1.3948 1.0855
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
92.25 27.76 11478 6873 1.6699 1.1332
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
93.96 27.76 769 6849 0.1123 0.5189
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
93.96 27.76 14270 6849 2.0835 1.1935
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
93.96 27.76 8631 6849 1.2602 1.0591
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
93.96 27.76 11568 6849 1.6890 1.1364
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
95.66 27.76 629 6712 0.0937 0.4831
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
95.66 27.76 14408 6712 2.1464 1.2025
MN20160318_Q01
I14
MCF 10A-H2B-mCherry Neratinib
0.00043333
95.66 27.76 8057 6712 1.2003 1.0466
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.00043333
95.66 27.76 11787 6712 1.7559 1.1474
MN20160318_Q01
L07
MCF 10A-H2B-mCherry Neratinib
0.0013333
1.95 27.76 1 225 0.0044 -0.6673
MN20160318_Q01
J13
MCF 10A-H2B-mCherry Neratinib
0.0013333
1.95 27.76 501 225 2.2253 1.6065
MN20160318_Q01
J13
MCF 10A-H2B-mCherry Neratinib
0.0013333
1.95 27.76 8 225 0.0355 -0.3377
MN20160318_Q01
M19
MCF 10A-H2B-mCherry Neratinib
0.0013333
1.95 27.76 714 225 3.1713 1.9310
MN20160318_Q01
M19
MCF 10A-H2B-mCherry Neratinib
0.0013333
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
J13
MCF 10A-H2B-mCherry Neratinib
0.0013333
3.66 27.76 599 283 2.1097 1.4985
MN20160318_Q01
J13
MCF 10A-H2B-mCherry Neratinib
0.0013333
3.66 27.76 13 283 0.0458 -0.2024
MN20160318_Q01
M19
MCF 10A-H2B-mCherry Neratinib
0.0013333
3.66 27.76 802 283 2.8247 1.7256
MN20160318_Q01
M19
MCF 10A-H2B-mCherry Neratinib
0.0013333
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
J13
MCF 10A-H2B-mCherry Neratinib
0.0013333
5.36 27.76 702 320 2.1913 1.4979
MN20160318_Q01
J13
MCF 10A-H2B-mCherry Neratinib
0.0013333
5.36 27.76 17 320 0.0531 -0.1297
MN20160318_Q01
M19
MCF 10A-H2B-mCherry Neratinib
0.0013333
5.36 27.76 896 320 2.7969 1.6768
MN20160318_Q01
M19